[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

APAC Gastric Cancer Market to Hit USD 27 Bn Mark in 2022, Predicts GBI Research in Its Report Available at MarketPublishers.com

24 Oct 2016 • by Natalie Aster

LONDON – At present, gastric cancer is in the top five most common types of cancer globally. Adenocarcinoma represents the most common type of this cancer: it accounts for more than 94.5% of cases. A stage of the disease represents the major factor determining the survival rate and life expectancy.

When it comes to the Asia-Pacific, this cancer is usually diagnosed in patients aged over sixty and at the late stage. The population continues to age and it is evident that the prevalence of this disease is set to grow.

In the meantime, the early diagnosis is one the rise, and the survival rate is improving. These factors are set to become revenue growth drivers. 

There is a pressing need for improved options in the field of targeted therapeutics. Cuttingly, patients are offered an extensive rate of treatment options. However, some need remain unmet, such as treatment of patients having HER2-negative gastric cancer. The complex treatment landscape becomes the major focus of this market and removes generic chemotherapy regimens from their leading position.

Recently launched products along with upcoming targeted therapies will drive this market. However, low penetration of new targeted therapies and limited healthcare budgets will restrain the growth.

As of 2015, the APAC marketplace hit a value of USD 1.3 billion. It is expected to hit the USD 2.7 billion mark in 2022.

In-demand research report “Gastric Cancer Therapeutics in Asia-Pacific Markets to 2022” elaborated by GBI Research offers a comprehensive analysis of the global gastric cancer marketplace. The study provides a 360-degree overview of the disease, its etiology, symptoms, diagnosis, prognosis, treatment, and more.

It casts light on marketed products and a detailed pipeline analysis. The report also comprises a clinical trial analysis. The research study investigates driving forces and barriers this space has. It concentrates on deals and strategic consolidations.

The research report highlights regional markets and sheds light on major counties in this region, such as Australia, China, Japan, etc. Future outlook for this marketplace is on hand in the study, too.

More insightful studies by GBI Research can be found at its page


The Market Publishers, Ltd.
Natalie Aster
Tel: +44 208 144 6009
Fax: +44 207 900 3970
[email protected]

Analytics & News

Weekly Digest